36 completed, 7 terminated, 3 withdrawn, 1 unknown. 16 Phase 1, 10 Phase 2, 2 Not applicable, 1 Early Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 16 | Completed 9, Terminated 6, Withdrawn 1 |
| Phase 2 | 10 | Completed 5, Terminated 4, Unknown 1 |
| Not applicable | 2 | Completed 1, Withdrawn 1 |
| Early Phase 1 | 1 | Completed 1 |
Follow western blotting: new trials by email Literature Review of western blotting trials Research Report on western blotting
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Studying Biomarkers in Samples From Younger Patients With Wilms Tumor gene expression analysis, proteomic profiling, reverse transcriptase-polymerase chain reaction - Kidney Cancer | Completed | Children's Oncology Group | 20 | 2012-02-01 | 2016-05-18 | |
| Biomarkers in Blood and Tissue Samples From Patients With Epstein-Barr Virus-Positive Hodgkin Lymphoma DNA analysis, RNA analysis, cytogenetic analysis - Lymphoma, Nonneoplastic Condition | Completed | Children's Oncology Group | 50 | 2011-12-01 | 2016-05-17 | |
| Role of Biomarkers in Disease Progression in Samples From Patients With Acute Myeloid Leukemia gene expression analysis, gene rearrangement analysis, polymerase chain reaction - Leukemia | Completed | Children's Oncology Group | 20 | 2011-12-01 | 2016-05-18 | |
| Protein Expression in Human Neuroblastoma Tumor Samples protein expression analysis, western blotting, laboratory biomarker analysis - Neuroblastoma | Completed | Children's Oncology Group | 20 | 2011-07-01 | 2016-05-17 | |
| Biomarkers in Blood and Tissue Samples From Patients With Newly Diagnosed Neuroblastoma RNA analysis, polymerase chain reaction, protein expression analysis - Neuroblastoma | Completed | Children's Oncology Group | 300 | 2011-06-01 | 2016-05-18 | |
| Methoxyamine and Fludarabine Phosphate in Treating Patients With Relapsed or Refractory Hematologic Malignancies fludarabine phosphate, methoxyamine, laboratory biomarker analysis - Adult Nasal Type Extranodal NK/T-cell Lymphoma, Anaplastic Large Cell Lymphoma | Phase 1 | Completed | Case Comprehensive Cancer Center | 20 | 2011-05-01 | 2015-08-13 |
| Biomarker Expression in Samples From Young Patients With Anaplastic Large Cell Lymphoma microarray analysis, protein expression analysis, western blotting - Lymphoma | Completed | Children's Oncology Group | 7 | 2011-05-01 | 2016-05-19 | |
| Biomarkers in Samples From Young Patients With Neuroblastoma polymerase chain reaction, protein expression analysis, western blotting - Neuroblastoma | Completed | Children's Oncology Group | 20 | 2011-05-01 | 2016-04-15 | |
| Panobinostat in Treating Patients With Relapsed or Refractory Non-Hodgkin Lymphoma panobinostat, laboratory biomarker analysis, western blotting - Adult Nasal Type Extranodal NK/T-cell Lymphoma, Anaplastic Large Cell Lymphoma | Phase 2 | Completed | Mayo Clinic | 41 | 2011-01-17 | 2022-05-24 |
| Azacitidine in Treating Patients With Triple Negative Stage I-IV Invasive Breast Cancer That Can Be Removed By Surgery azacitidine, laboratory biomarker analysis, immunohistochemistry staining method - Recurrent Breast Cancer, Stage IA Breast Cancer | Not applicable | Withdrawn | University of Southern California | 2011-01-01 | 2014-02-06 | |
| Bafetinib in Treating Patients With Recurrent High-Grade Glioma or Brain Metastases bafetinib, microdialysis, pharmacological study - Adult Anaplastic Astrocytoma, Adult Anaplastic Ependymoma | Phase 1 | Completed | City of Hope Medical Center | 7 | 2010-12-01 | 2018-04-17 |
| Azadirachta Indica in Treating Patients With Chronic Lymphocytic Leukemia laboratory biomarker analysis, western blotting, gene expression analysis - Refractory Chronic Lymphocytic Leukemia, Stage II Chronic Lymphocytic Leukemia | Phase 1 | Withdrawn | Roswell Park Cancer Institute | 2010-12-01 | 2014-01-13 | |
| Drug Biomarkers in Cell Samples From Patients With Acute Myeloid Leukemia western blotting, flow cytometry, laboratory biomarker analysis - Leukemia | Completed | Children's Oncology Group | 40 | 2010-11-01 | 2015-05-12 | |
| Biomarkers in Tissue Samples From Patients With Acute Promyelocytic Leukemia protein expression analysis, western blotting, flow cytometry - Leukemia | Completed | Children's Oncology Group | 10 | 2010-11-01 | 2015-10-02 | |
| Entinostat And Imatinib Mesylate In Treating Patients With Relapsed or Refractory Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia entinostat, imatinib mesylate, laboratory biomarker analysis - Philadelphia Chromosome Positive Adult Precursor Acute Lymphoblastic Leukemia, Recurrent Adult Acute Lymphoblastic Leukemia | Phase 1 / Phase 2 | Terminated | National Cancer Institute (NCI) | 2 | 2010-10-01 | 2017-08-08 |
| Panobinostat and Fluorouracil Followed By Leucovorin Calcium in Treating Patients With Stage IV Colorectal Cancer Who Did Not Respond to Previous Fluorouracil-Based Chemotherapy panobinostat, fluorouracil, leucovorin calcium - Recurrent Colon Cancer, Recurrent Rectal Cancer | Phase 1 | Terminated | University of Southern California | 7 | 2010-10-01 | 2015-05-27 |
| Obatoclax Mesylate in Samples From Young Patients With Acute Myeloid Leukemia gene expression analysis, microarray analysis, protein expression analysis - Leukemia | Completed | Children's Oncology Group | 50 | 2010-06-01 | 2016-05-18 | |
| Prognostic Biomarkers in Samples From Young Patients With Acute Myeloid Leukemia protein expression analysis, western blotting, flow cytometry - Leukemia | Completed | Children's Oncology Group | 150 | 2010-05-01 | 2016-05-18 | |
| Belinostat and Bortezomib in Treating Patients With Relapsed or Refractory Acute Leukemia or Myelodysplastic Syndrome bortezomib, belinostat, laboratory biomarker analysis - Acute Lymphocytic Leukemia, Acute Myeloid Leukemia | Phase 1 | Completed | Virginia Commonwealth University | 41 | 2010-05-01 | 2016-04-15 |
| Biomarkers in Blood and Tissue Samples From Patients With Uterine Cancer Diagnostic Laboratory Biomarker Analysis, Immunohistochemistry Staining Method, Medical Chart Review - Endometrial Serous Adenocarcinoma, Stage I Uterine Corpus Cancer | Completed | Gynecologic Oncology Group | 360 | 2010-01-01 | 2024-08-14 |
Showing 20 of 47. Sign in to see all of them.
Leukemia (12) · Leukemia, Lymphocytic, Chronic, B-Cell (6) · Lymphoma (5) · Precursor Cell Lymphoblastic Leukemia-Lymphoma (5) · Burkitt Lymphoma (4) · Colonic Neoplasms (4) · Leukemia, Myeloid, Acute (4) · Lymphoma, B-Cell, Marginal Zone (4) · Lymphoma, Follicular (4) · Lymphoma, Large B-Cell, Diffuse (4) · Lymphoma, Large-Cell, Anaplastic (4) · Neuroblastoma (4) · Sarcoma (4) · Breast Neoplasms (3) · Colorectal Neoplasms (3)
Children's Oncology Group (13) · City of Hope Medical Center (6) · Roswell Park Cancer Institute (3) · Mayo Clinic (2) · University of Southern California (2) · Wake Forest University Health Sciences (2) · AIDS Malignancy Consortium (1) · Abramson Cancer Center at Penn Medicine (1) · Alliance for Clinical Trials in Oncology (1) · Auxilio Mutuo Cancer Center (1) · Cancer Research UK (1) · Case Comprehensive Cancer Center (1) · Duke University (1) · Fox Chase Cancer Center (1) · Georgetown University (1)
United States (27) · Puerto Rico (1) · United Kingdom (1)
Michele S. Redell, MD, PhD (2) · Agustin Garcia, MD (1) · Asher Chanan-Khan (1) · Barbara Buttin (1) · Beata Holkova, MD (1) · Carolyn A. Felix, MD (1) · David Hema, MD, MPH (1) · Douglas S. Tyler, MD (1) · Erin G. Reid, MD (1) · Evan Yu (1) · Fernando Cabanillas, MD (1) · Francisco Hernandez-ILizaliturri (1) · Harold N. Lovvorn, III, MD (1) · Harry A. Drabkin, MD (1) · Heinz-Josef Lenz (1)
PMID 23380277, PMID 24383844, PMID 25527568, PMID 26903311, PMID 30573564, PMID 36110959
P30CA033572 (4), P01HL048546 (1), P30CA012197 (1), P30CA015083 (1), P30CA023074 (1), P30CA051008 (1), P30CA072720 (1), R21CA135467 (1), RC2CA148431 (1), U01CA070095 (1), U01CA121947 (1), U10CA027469 (1), U10CA032102 (1), U10CA037517 (1)